We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Unit-Dose Twist-Tip BFS
Gold Supplier
Procalcitonin Test
Gold Supplier
CLIA Analyzer
Diagnostic Salivary DHEA ELISA Kit
Salimetrics Salivary DHEA Enzyme Immunoassay Kit
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.


Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)

Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics

Since the year 2003, Tianlong Science and Technology (Shaanxi, China) has witnessed several health crises globally and has also contributed to China’s power to prevent and control major epidemics. More...
02 Jan 2023
Image: The global urinalysis market is projected to reach USD 4.9 billion by 2026 (Photo courtesy of Pexels)

Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases

The global urinalysis market is projected to reach USD 4.9 billion by 2026, driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests. More...
22 Dec 2022
Image: Dynamyx is FDA’s first and only clearance for digital pathology software with multiple scanners (Photo courtesy of Inspirata)

Fujifilm Enters Digital Pathology Space with Acquisition of Inspirata

FUJIFILM Corporation (Tokyo, Japan) has entered into an asset purchase agreement to acquire the global digital pathology business of Inspirata, Inc. (Tampa, FL, USA). The addition of digital pathology will expand Fujifilm’s robust Synapse Enterprise Imaging offering to enable the integration of pathology images and data into a healthcare organization’s electronic health record system and help to streamline care delivery for oncology patients and provider teams. More...
22 Dec 2022
Image: The global point-of-care diagnostics market is expected to surpass USD 93 billion by 2030 (Photo courtesy of Pexels)

Global POC Diagnostics Market Driven by Growing Demand for Portable and Handheld Near-Patient Devices

The global POC diagnostics market is projected to grow at a CAGR of 11.1% from USD 39.91 billion in 2022 to USD 93.21 billion by 2030, driven by the rising incidence of chronic diseases such as cardiovascular disorders, diabetes, and infectious diseases, as well as an increasing geriatric population. More...
20 Dec 2022
Image: The global microplate readers market is expected to grow at a CAGR of around 12% from 2022-2028 (Photo courtesy of Pexels)

Global Microplate Readers Market Driven by Rising Incidence of Infectious Diseases

The global microplate readers market which was valued at USD 550 million in 2020 is expected to grow at a CAGR of around 12% from 2022-2028, driven by the rising incidence of infectious diseases and increasing adoption of automated platforms in diagnostic laboratories. More...
14 Dec 2022
Image: The AI-based digital pathology solutions market is expected to register a CAGR of 7.67% during 2022-2030 (Photo courtesy of Pexels)

AI-Based Digital Pathology Solutions Market Driven by Benefits of More Precise and Reproducible Diagnoses

The global AI-based digital pathology solutions market is expected to grow at a CAGR of 7.67% during the forecast period 2022-30, driven by the increasing prevalence of diseases, significance of digital pathology for the pharmaceutical industry, and approval by regulatory agencies for the use of digital pathology in primary diagnosis. More...
09 Dec 2022
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services. More...
09 Nov 2022

LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2023 Globetech Media. All rights reserved.